USA Penny StockBest Stock Under $3 for 2022 ObsEva Stock
ObsEva produces therapeutics targeted at women’s reproductive health2 Reasons to consider investing in OBSV stock
First of all, ObsEva reported a net gain of $800,000 for the quarter that ended Sept. 30.ObsEva reported a cash position of $62.9 million, up from $31.2 million at the end of 2020.
Positive factor behind ObsEva: That is, it recently was added to the Nasdaq Biotechnology Index
Don't Miss Penny Stocks
The other encouraging sign is that ObsEva’s target price of $10.75 is well above its current price of $2.